3.50
前日終値:
$3.68
開ける:
$3.57
24時間の取引高:
117.36K
Relative Volume:
1.34
時価総額:
$149.99M
収益:
-
当期純損益:
$-19.90M
株価収益率:
-6.6038
EPS:
-0.53
ネットキャッシュフロー:
$-19.80M
1週間 パフォーマンス:
-8.38%
1か月 パフォーマンス:
-42.15%
6か月 パフォーマンス:
-19.72%
1年 パフォーマンス:
+18.64%
Diamedica Therapeutics Inc Stock (DMAC) Company Profile
名前
Diamedica Therapeutics Inc
セクター
電話
(763) 496-5454
住所
301 CARLSON PARKWAY, MINNEAPOLIS, MN
DMAC を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
DMAC
Diamedica Therapeutics Inc
|
3.50 | 149.99M | 0 | -19.90M | -19.80M | -0.53 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-10-07 | 開始されました | H.C. Wainwright | Buy |
2024-04-24 | 再開されました | Craig Hallum | Buy |
2023-06-22 | アップグレード | Oppenheimer | Perform → Outperform |
2021-04-09 | 開始されました | Oppenheimer | Outperform |
2021-02-17 | 開始されました | ROTH Capital | Buy |
2020-10-30 | 開始されました | Guggenheim | Buy |
2020-07-08 | 開始されました | Maxim Group | Buy |
2019-04-30 | 開始されました | Dougherty & Company | Buy |
2019-03-05 | 開始されました | Lake Street | Buy |
すべてを表示
Diamedica Therapeutics Inc (DMAC) 最新ニュース
DiaMedica Therapeutics (NASDAQ:DMAC) Price Target Raised to $10.00 - Defense World
Equities Analysts Offer Predictions for DMAC Q1 Earnings - Defense World
DiaMedica Therapeutics Reports 2024 Financial Results - TipRanks
DiaMedica Therapeutics Announces Closing of $8.5 Million Public Offering of Common Shares - Business Wire
H.C. Wainwright lifts DiaMedica stock target to $10 on trial hopes - Investing.com Canada
H.C. Wainwright lifts DiaMedica stock target to $10 on trial hopes By Investing.com - Investing.com South Africa
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2024 Earnings Call Transcript - Insider Monkey
DiaMedica Therapeutics Inc (DMAC) Q4 2024 Earnings Call Highlights: Strong Financial Position ... - Yahoo
DiaMedica Therapeutics’ Optimistic Earnings Call Highlights - TipRanks
Earnings call transcript: DiaMedica Q4 2024 results and stock surge By Investing.com - Investing.com South Africa
Earnings call transcript: DiaMedica Q4 2024 results and stock surge - Investing.com India
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results - BioSpace
DiaMedica Therapeutics Reports 2024 Financial Results and Strategic Advancements - TipRanks
DiaMedica Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
DIAMEDICA THERAPEUTICS Earnings Results: $DMAC Reports Quarterly Earnings - Nasdaq
Insider Stock Buying Reaches US$9.00m On DiaMedica Therapeutics - Yahoo Finance
Where are the Opportunities in (DMAC) - Stock Traders Daily
DIAMEDICA THERAPEUTICS Earnings Preview: Recent $DMAC Insider Trading, Hedge Fund Activity, and More - Nasdaq
DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025 - Business Wire
DiaMedica Therapeutics (DMAC) to Release Quarterly Earnings on Tuesday - Defense World
Insiders At DiaMedica Therapeutics See Good Returns After Buying Stock Worth US$9.00m - Simply Wall St
DiaMedica Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
DiaMedica announces board member Richard Pilnik’s retirement - Investing.com
DiaMedica announces board member Richard Pilnik’s retirement By Investing.com - Investing.com South Africa
Trading (DMAC) With Integrated Risk Controls - Stock Traders Daily
Y Intercept Hong Kong Ltd Takes $81,000 Position in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World
DiaMedica Therapeutics Appoints Daniel J. O’Connor to Board - MSN
DiaMedica welcomes new board member with biopharma leadershi By Investing.com - Investing.com Nigeria
DiaMedica welcomes new board member with biopharma leadershi - Investing.com
DiaMedica Therapeutics Appoints Daniel J. O’Connor to the Board of Directors - Business Wire
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Short Interest Down 8.4% in January - MarketBeat
DiaMedica reports on DM199 stroke treatment mechanism By Investing.com - Investing.com Nigeria
DiaMedica reports on DM199 stroke treatment mechanism - Investing.com
DiaMedica Therapeutics Announces Publication Of Dm199'S Mechanism Of Action For The Treatment Of Acute Ischemic Stroke In The Journal Stroke - Marketscreener.com
DiaMedica Therapeutics Announces Publication of DM199’s Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke - Business Wire
Learn to Evaluate (DMAC) using the Charts - Stock Traders Daily
DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
DiaMedica's Game-Changing Stroke Treatment Takes Center Stage at Major Healthcare Conference (DMAC) - Stock Titan
Short Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Grows By 14.5% - MarketBeat
DiaMedica Therapeutics (NASDAQ:DMAC) Trading Down 1.5%Here's Why - MarketBeat
DiaMedica Therapeutics: Interesting Work In Treating Ischemic Stroke - Seeking Alpha
Geode Capital Management LLC Purchases 70,070 Shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World
Diamedica Therapeutics Inc (DMAC) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):